Nephi in Podcasts
productNephi is a nasal spray product developed by ARS Pharmaceuticals for emergency treatment of allergic reactions.
Mentions Over Time
2
mentions
1
related entities
Discussed alongside in this corpus
Audioscrape has indexed podcast episodes that discuss Nephi together with the following entities. Each link opens the other entity's page; hover over the contextual tag for the most common relationship our index has captured.
Mentions in Podcasts
FEAR & GREED | Business News
Q+A: The $2 trillion asset class most investors overlook
Nephi, the nasal inhaler that I just mentioned, is unique for treating severe allergic reactions, and it will be for the next five, 10 years.
Vanguards of Healthcare by Bloomberg Intelligence
ARS Pharma’s Clinical Differentiation
The company is commercializing Nephi, which was approved August of last year, an epinephrine nasal spray for emergency treatment, including anaphylaxis.